
NASDAQHealthcareBiotechnology
Latest quote
$6.50
$0.00 · 0.00%
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
Previous close
$6.50
$0.00 · 0.00%
Regular session · ET · Market data may be delayed.
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
Day range
Current $6.50
52-week range
Current $6.50
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
91
Deep Value
Sentiment
52
Mixed
Risk
70
High Risk
Momentum
18
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
Day range
Current $6.50
52-week range
Current $6.50
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | — | — | 8.31M USD | 14.27M USD | 12.35M USD |
| Selling, general, and administrative | 2.34M USD | 9.3M USD | 9.46M USD | 5.65M USD | 4.94M USD |
| Operating expenses | 2.37M USD | 25.95M USD | 19.29M USD | 20.03M USD | 17.32M USD |
| Interest income | 172K USD | 809K USD | 1.77M USD | 1.05M USD | 101K USD |
| Interest expense | 185K USD | 9K USD | 13K USD | 12K USD | 13K USD |
| Depreciation and amortization | 34K USD | 161K USD | 212K USD | 404K USD | 205K USD |
| Operating income | −2.37M USD | −25.95M USD | −19.29M USD | −20.03M USD | −17.32M USD |
| Net income | 4.14M USD | −25.15M USD | −17.57M USD | −19.11M USD | −17.2M USD |
Company facts updated Sep 7, 2026.
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 13, 2026 | 1:7 | — | — |
Stock split | Nov 25, 2022 | 1:20 | — | — |
Stock split | Apr 4, 2018 | 1:12 | — | — |
Effective Aug 13, 2026
1:7
Effective Nov 25, 2022
1:20
Effective Apr 4, 2018
1:12
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.